Deborah Miller
General Counsel bei NUVALENT, INC.
Vermögen: 2 Mio $ am 31.05.2024
Aktive Positionen von Deborah Miller
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NUVALENT, INC. | General Counsel | 01.06.2021 | - |
| Unternehmenssekretär | - | - |
Karriereverlauf von Deborah Miller
Ehemalige bekannte Positionen von Deborah Miller
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Sumitomo Dainippon Pharma America, Inc. | Corporate Officer/Principal | 01.04.2020 | 01.06.2021 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01.03.2017 | 01.04.2020 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2010 | 01.03.2017 |
Nutter McClennen & Fish LLP
 Nutter McClennen & Fish LLP Miscellaneous Commercial ServicesCommercial Services Nutter McClennen & Fish LLP provides legal services. The firm serves to banking and financial services, energy, food and beverage, government entities, health care, information and technology, life science and manufacturing industries. The company was founded by Louis D. Brandeis and Samuel D. Warren in 1879 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Ausbildung von Deborah Miller
| Harvard University | Doctorate Degree |
| Swarthmore College | Undergraduate Degree |
| Harvard Medical School | Graduate Degree |
| Suffolk University Law School | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 10 |
Operativ
| Corporate Officer/Principal | 4 |
| Graduate Degree | 2 |
| General Counsel | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| NUVALENT, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
Nutter McClennen & Fish LLP
Nutter McClennen & Fish LLP Miscellaneous Commercial ServicesCommercial Services Nutter McClennen & Fish LLP provides legal services. The firm serves to banking and financial services, energy, food and beverage, government entities, health care, information and technology, life science and manufacturing industries. The company was founded by Louis D. Brandeis and Samuel D. Warren in 1879 and is headquartered in Boston, MA. | Commercial Services |
| Sumitomo Dainippon Pharma America, Inc. |
- Börse
- Insiders
- Deborah Miller
- Erfahrung
